ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.
NCT00040625 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS
Last updated 2007-03-15
Summary
This study is to evaluate the effects (good and bad) of ALIMTA and Cisplatin or ALIMTA alone on you and your malignant pleural mesothelioma as well as make ALIMTA available to patients who qualify for treatment.
Conditions
Interventions
- DRUG
-
Pemetrexed
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
- Brazil
- Egypt
- Saudi Arabia
Study Locations
More Related Trials
-
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
NCT00165503 ·Status: TERMINATED ·Phase: PHASE2
-
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
NCT00402766 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
NCT00251550 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer
NCT00482014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma
NCT01281800 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma
NCT00192088 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery
NCT00005636 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing 3 Schedules of Alimta Plus Gemzar
NCT00034606 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
NCT00087711 ·Status: COMPLETED ·Phase: PHASE3
-
Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer
NCT00259285 ·Status: TERMINATED ·Phase: PHASE2
-
Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
NCT00386815 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC
NCT01742767 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy
NCT00630149 ·Status: COMPLETED ·Phase: PHASE2
-
Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma
NCT00470405 ·Status: COMPLETED ·Phase: PHASE1
-
Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT00071136 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
NCT00458913 ·Status: COMPLETED ·Phase: PHASE2
-
Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.
NCT00061464 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer
NCT00078260 ·Status: COMPLETED ·Phase: PHASE3
-
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
NCT00004920 ·Status: COMPLETED ·Phase: PHASE3
-
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
NCT00541073 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer
NCT00101842 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium
NCT00035061 ·Status: COMPLETED ·Phase: PHASE2
-
Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma
NCT05449366 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
NCT00034619 ·Status: COMPLETED ·Phase: PHASE2
-
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
NCT02611037 ·Status: COMPLETED ·Phase: PHASE2